Title: Therapeutic phages and methods thereof

Abstract

The present invention relates, in part, to engineered viruses (e.g., engineered phages), phage cocktails, and methods of producing and/or identifying viruses for targeting pathogenic bacteria.

Inventors:

Williams, Kelly Porter; Branda, Steven; Krishnakumar, Raga

Issue Date:

2021-07-20

Research Org.:

Sandia National Lab. (SNL-CA), Livermore, CA (United States)

Sponsoring Org.:

USDOE National Nuclear Security Administration (NNSA)

OSTI Identifier:

1840275

Patent Number(s):

11066691

Application Number:

16/570,197

Assignee:

National Technology & Engineering Solutions of Sandia, LLC (Albuquerque, NM)

Patent Classifications (CPCs):

C - CHEMISTRY C12 - BIOCHEMISTRY C12N - MICROORGANISMS OR ENZYMES

C - CHEMISTRY C12 - BIOCHEMISTRY C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS

Show more

C - CHEMISTRY C12 - BIOCHEMISTRY C12N - MICROORGANISMS OR ENZYMES

C12N15/1034 - {Isolating an individual clone by screening libraries}
C12N2795/00021 - Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N2795/00032 - Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
C12N7/00 - Viruses

C - CHEMISTRY C12 - BIOCHEMISTRY C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS

C12Q1/04 - Determining presence or kind of microorganism
C12Q1/18 - Testing for antimicrobial activity of a material
C12Q1/6888 - for detection or identification of organisms

Show less

DOE Contract Number:  

NA0003525

Resource Type:

Patent

Resource Relation:

Patent File Date: 09/13/2019

Country of Publication:

United States

Language:

English